Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema-Reference-Cited by-同舟云学术

Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema

Published:2017-11 Issue:6 Volume:5 Page:1671-1678.e2
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Farkas Henriette^ORCID,Reshef Avner^ORCID,Aberer Werner,Caballero Teresa^ORCID,McCarthy Laura,Hao James,Nothaft Wolfram,Schranz Jennifer,Bernstein Jonathan A.,Li H. Henry

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference39 articles.

1. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group;Cicardi;Allergy,2014

2. Structure and function of C1-inhibitor;Wagenaar-Bos;Immunol Allergy Clin North Am,2006

3. Molecular genetics of C1 inhibitor;Tosi;Immunobiology,1998

4. The pathophysiology of hereditary angioedema;Zuraw;World Allergy Organization J,2010

5. Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene;Levy;Proc Natl Acad Sci U S A,1990

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Therapeutics in Hereditary Angioedema;Immunology and Allergy Clinics of North America;2024-08

2. Hereditäres Angioödem durch C1-Inhibitor-Mangel, eine nationale Versorgungsleitlinie;Wiener klinische Wochenschrift;2023-11

3. Hereditary Angioedema: A Review of the Current and Evolving Treatment Landscape;The Journal of Allergy and Clinical Immunology: In Practice;2023-08

4. Not a small frog in a big pond: targeting bradykinin receptor B2 signaling in vascular smooth muscle cells for treatment of hypertension;Hypertension Research;2023-07-28

5. Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open‐label study;The Journal of Dermatology;2023-06-29